Lotta Schepel
Overview
Explore the profile of Lotta Schepel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kvarnstrom K, Niittynen I, Kallio S, Linden-Lahti C, Airaksinen M, Schepel L
Int J Environ Res Public Health
. 2023 Jun;
20(12).
PMID: 37372745
Long-term continuing education programs have been a key factor in shifting toward more patient-centered clinical pharmacy services. This narrative review aims to describe the development of Helsinki University Hospital (HUS)...
2.
Harkanen M, Syyrila T, Schepel L
BMJ Qual Saf
. 2022 Nov;
32(4):189-191.
PMID: 36411038
No abstract available.
3.
Linden-Lahti C, Kivivuori S, Lehtonen L, Schepel L
Healthcare (Basel)
. 2022 Jun;
10(6).
PMID: 35742071
Closed-loop electronic medication management systems (EMMS) have been seen as a potential technology to prevent medication errors (MEs), although the research on them is still limited. The aim of this...
4.
Kuitunen S, Karkkainen K, Linden-Lahti C, Schepel L, Holmstrom A
BMC Pediatr
. 2022 Mar;
22(1):118.
PMID: 35255846
Background: Smart infusion pumps with dose error reduction software can be used to prevent harmful medication errors. The aim of this study was to develop a method for defining and...
5.
Virtanen S, Kapp K, Rautamo M, Schepel L, Linden-Lahti C, Cruz C, et al.
Healthcare (Basel)
. 2021 Aug;
9(8).
PMID: 34442162
Parenteral products must be compounded using an aseptic technique to ensure sterility of the medicine. We compared the effect of three clinical environments as compounding areas as well as different...
6.
Schepel L, Aronpuro K, Kvarnstrom K, Holmstrom A, Lehtonen L, Lapatto-Reiniluoto O, et al.
Res Social Adm Pharm
. 2019 Apr;
15(7):873-882.
PMID: 30928317
Background: Medication safety risks are the most important preventable factors jeopardizing patient safety. To manage these risks, extending pharmacists' involvement in patient care and patient safety work has been systematically...
7.
Schepel L, Lehtonen L, Airaksinen M, Ojala R, Ahonen J, Lapatto-Reiniluoto O
Int J Risk Saf Med
. 2018 Aug;
30(1):19-31.
PMID: 30103352
Background: 10-30% of hospital stays by older patients are drug-related. The admission phase is important for identifying drug-related problems, but taking an incorrect medication history often leads to medication errors....
8.
Schepel L, Lehtonen L, Airaksinen M, Lapatto-Reiniluoto O
J Patient Saf
. 2018 Jul;
17(8):e1358-e1363.
PMID: 29994819
Objectives: High-alert medications may cause significant patient harm when used in error. Hospital-specific safety data should be used to customize high-alert medication lists to fit the local context. The aim...